A detailed history of Retirement Systems Of Alabama transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Retirement Systems Of Alabama holds 1,412,387 shares of BMY stock, worth $81.3 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,412,387
Previous 1,506,791 6.27%
Holding current value
$81.3 Million
Previous $62.6 Million 16.8%
% of portfolio
0.28%
Previous 0.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 06, 2024

SELL
$39.66 - $51.75 $3.74 Million - $4.89 Million
-94,404 Reduced 6.27%
1,412,387 $73.1 Million
Q2 2024

Jul 24, 2024

BUY
$40.25 - $52.99 $5.66 Million - $7.45 Million
140,574 Added 10.29%
1,506,791 $62.6 Million
Q1 2024

Apr 30, 2024

BUY
$47.98 - $54.4 $31,570 - $35,795
658 Added 0.05%
1,366,217 $74.1 Million
Q4 2023

Feb 05, 2024

BUY
$48.48 - $57.85 $3.18 Million - $3.79 Million
65,492 Added 5.04%
1,365,559 $70.1 Million
Q3 2023

Nov 06, 2023

SELL
$57.89 - $64.73 $295,586 - $330,511
-5,106 Reduced 0.39%
1,300,067 $75.5 Million
Q2 2023

Jul 31, 2023

SELL
$63.71 - $70.74 $9.62 Million - $10.7 Million
-150,963 Reduced 10.37%
1,305,173 $83.5 Million
Q1 2023

May 01, 2023

BUY
$65.71 - $74.53 $3.83 Million - $4.34 Million
58,297 Added 4.17%
1,456,136 $101 Million
Q4 2022

Feb 06, 2023

SELL
$68.48 - $81.09 $1.92 Million - $2.28 Million
-28,085 Reduced 1.97%
1,397,839 $101 Million
Q3 2022

Nov 04, 2022

SELL
$0.13 - $76.84 $31,861 - $18.8 Million
-245,085 Reduced 14.67%
1,425,924 $101 Million
Q2 2022

Aug 03, 2022

SELL
$72.62 - $79.98 $3.7 Million - $4.08 Million
-50,994 Reduced 2.96%
1,671,009 $129 Million
Q1 2022

Apr 20, 2022

SELL
$61.48 - $73.72 $816,024 - $978,485
-13,273 Reduced 0.76%
1,722,003 $126 Million
Q4 2021

Jan 20, 2022

SELL
$53.63 - $62.52 $1.48 Million - $1.73 Million
-27,617 Reduced 1.57%
1,735,276 $108 Million
Q3 2021

Nov 03, 2021

SELL
$59.17 - $69.31 $3.2 Million - $3.75 Million
-54,082 Reduced 2.98%
1,762,893 $104 Million
Q2 2021

Jul 21, 2021

SELL
$61.91 - $67.42 $1.14 Million - $1.25 Million
-18,493 Reduced 1.01%
1,816,975 $121 Million
Q1 2021

Apr 15, 2021

SELL
$59.34 - $66.74 $4.17 Million - $4.69 Million
-70,240 Reduced 3.69%
1,835,468 $116 Million
Q4 2020

Jan 26, 2021

BUY
$57.74 - $65.43 $14.7 Million - $16.6 Million
254,268 Added 15.4%
1,905,708 $118 Million
Q3 2020

Oct 20, 2020

SELL
$57.43 - $63.64 $10.9 Million - $12.1 Million
-190,219 Reduced 10.33%
1,651,440 $99.6 Million
Q2 2020

Jul 23, 2020

SELL
$54.82 - $64.09 $3.46 Million - $4.04 Million
-63,032 Reduced 3.31%
1,841,659 $108 Million
Q1 2020

Apr 20, 2020

BUY
$46.4 - $67.43 $11,275 - $16,385
243 Added 0.01%
1,904,691 $106 Million
Q4 2019

Jan 28, 2020

BUY
$49.21 - $64.19 $15.4 Million - $20.2 Million
313,920 Added 19.74%
1,904,448 $122 Million
Q3 2019

Oct 30, 2019

SELL
$42.77 - $50.71 $7.34 Million - $8.7 Million
-171,533 Reduced 9.73%
1,590,528 $80.7 Million
Q2 2019

Jul 09, 2019

BUY
$44.62 - $49.34 $5.69 Million - $6.3 Million
127,617 Added 7.81%
1,762,061 $79.9 Million
Q1 2019

Apr 15, 2019

BUY
$45.12 - $53.8 $6.58 Million - $7.85 Million
145,890 Added 9.8%
1,634,444 $78 Million
Q4 2018

Jan 10, 2019

BUY
$48.76 - $63.23 $35.9 Million - $46.5 Million
736,000 Added 97.8%
1,488,554 $77.4 Million
Q3 2018

Oct 24, 2018

SELL
$55.19 - $62.25 $803,290 - $906,048
-14,555 Reduced 1.9%
752,554 $46.7 Million
Q2 2018

Jul 17, 2018

SELL
$50.53 - $62.98 $646,986 - $806,395
-12,804 Reduced 1.64%
767,109 $42.5 Million
Q1 2018

Apr 27, 2018

SELL
$59.92 - $68.98 $794,119 - $914,191
-13,253 Reduced 1.67%
779,913 $49.3 Million
Q4 2017

Feb 08, 2018

SELL
$59.94 - $65.35 $27.4 Million - $29.9 Million
-457,451 Reduced 36.58%
793,166 $48.6 Million
Q3 2017

Nov 06, 2017

BUY
$55.23 - $63.74 $69.1 Million - $79.7 Million
1,250,617
1,250,617 $79.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Retirement Systems Of Alabama Portfolio

Follow Retirement Systems Of Alabama and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.